| MicroRNAs as biomarkers for psychiatric conditions: a review of current research A Narahari, M Hussain, V Sreeram Innovations in clinical neuroscience 14 (1-2), 53, 2017 | 61 | 2017 |
| Age-related changes in binding of the D2/3 receptor radioligand [11C](+) PHNO in healthy volunteers D Matuskey, P Worhunksy, E Correa, B Pittman, JD Gallezot, N Nabulsi, ... Neuroimage 130, 241-247, 2016 | 41 | 2016 |
| Do cannabis use disorders increase medication non-compliance in schizophrenia?: United States Nationwide inpatient cross-sectional study RS Patel, V Sreeram, R Vadukapuram, R Baweja Schizophrenia research 224, 40-44, 2020 | 16 | 2020 |
| A national study for regional variation of inpatient ECT utilization from 4,411 hospitals across the United States. RS Patel, V Sreeram, T Thakur, R Bachu, NA Youssef Annals of clinical psychiatry: official journal of the American Academy of …, 2019 | 14 | 2019 |
| Role of vesicular monoamine transporter 2 inhibitors in tardive dyskinesia management V Sreeram, S Shagufta, F Kagadkar Cureus 11 (8), 2019 | 11 | 2019 |
| Association of opioid use with cardiometabolic disease risk factors: evidence from the 2009-2018 National Health And Nutrition Examination Survey K Shah, VV Joshi, NC Arinze, KP Bodicherla, S Ghimire, R Singh, ... Cureus 12 (6), 2020 | 3 | 2020 |
| Translational science of psychosis in Parkinson’s disease SA Farheen, P Shah, M Gill, S Ayaz, S Singh Clin Depress 1 (102), 2572-0791, 2015 | 2 | 2015 |
| Suicide: a complex phenomenon, risk assessment, a dilemma of emergency room physicians S Ahmed, M Hussain, S Virani, S Dar, V Sreeram J Addict Res Ther 6 (245), 2, 2015 | 2 | 2015 |
| 183 AXONA (Caprylidene): Medical Food Therapy For Alzheimer’s Disease S Shagufta, V Sreeram, F Kagadkar CNS Spectrums 23 (1), 105-105, 2018 | 1 | 2018 |
| Genetics and Dissociative Identity Disorder (DID) N Bonsu, V Sreeram, FM Hasan Dissociative Identity Disorder: Treatment and Management, 133-135, 2024 | | 2024 |
| Dissociative Identity Disorder and the Human Brain; Neuroanatomy FM Hasan, N Bonsu, V Sreeram Dissociative Identity Disorder: Treatment and Management, 137-140, 2024 | | 2024 |
| Struggle of Family of DID Patients. V Sreeram, N Bonsu, FM Hasan Dissociative Identity Disorder: Treatment and Management, 165-168, 2024 | | 2024 |
| Neuroleptic Induced Parkinsonism and Catatonia-A Case Report S Gehlot, V Sreeram, S Balan The American Journal of Geriatric Psychiatry 30 (4), S109-S110, 2022 | | 2022 |
| Breakthrough Therapy in Tardive Dyskinesia: Deutetrabenazine F Kagadkar, S Taha, V Sreeram PSYCH CONGRESS, 2017 | | 2017 |
| 2.9 Electronic Cognitive-Behavioral Therapy (eCBT) Smartphone Applications: A Comparative Analysis Among Adolescents A Sareen, V Sreeram, I Peñuelas-Calvo Journal of the American Academy of Child & Adolescent Psychiatry 56 (10), S179, 2017 | | 2017 |
| Transcranial Direct Current Stimulation (tDCS) Therapy for Major Depressive Disorder in the HIV Population: A Safe, Effective Noninvasive Promising Treatment as Compared to … S Ahmed, M Hussain, H Manzoor, V Sreeram, S Dar, S Amin, R Ahmed, ... J Addict Res Ther 6 (241), 2, 2015 | | 2015 |
| Clinical Depression A Narahari, M Hussain, V Sreeram | | 2015 |
| AXONA (Caprylidene): Medical Food Therapy For Alzheimer’s Disease S Shagufta, V Sreeram, F Kagadkar | | |
| Current Use and Trends in the Management of Tardive Dyskinesia: Role of VMAT2 Inhibitors V Sreeram, S Shagufta | | |
Rikinkumar S. PatelDuke UniversityVerified email at duke.edu
